RxNorm 2055645 NDC Crossover
lanadelumab-flyo 300 MG in 2 ML Injection
Related NDC Codes to RxNorm Concept 2055645
The following NDC codes crossover to the RxNorm Concept 2055645. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 47783-644 | Takhzyro | Lanadelumab-flyo | Injection, Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
| 47783-645 | Takhzyro | Lanadelumab-flyo | Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
| 47783-646 | Takhzyro | Lanadelumab-flyo | Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE |